Trinucleotide repeat length and progression of illness in Huntington's disease. - Wikidata - awgldk - TriplyDB

Trinucleotide repeat length and progression of illness in Huntington's disease.

Trinucleotide repeat length and progression of illness in Huntington's disease.

http://www.wikidata.org/entity/Q33596210

about

Therapeutic interventions for symptomatic treatment in Huntington's disease Therapeutic interventions for disease progression in Huntington's disease Seeking brain biomarkers for preventive therapy in Huntington disease.Bovine proteins containing poly-glutamine repeats are often polymorphic and enriched for components of transcriptional regulatory complexes.Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease.The selective vulnerability of nerve cells in Huntington's disease.Neurological proteins are not enriched for repetitive sequences.Thalamic metabolism and symptom onset in preclinical Huntington's disease.A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study.The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size Differences in duration of Huntington's disease based on age at onset.Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease.Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease.COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.Assessing Decline: Visualising Progression in Huntington's Disease using a Clinical Dashboard with Enroll-HD Data.Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene.Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression?Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.New insight into neurodegeneration: the role of proteomics.The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials.Genetic modifiers of Huntington's disease.Huntington's Disease: Relationship Between Phenotype and Genotype.Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.Hereditary chorea - what else to consider when the Huntington's disease genetics test is negative?Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics.Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models.The genetic defect causing Huntington's disease: repeated in other contexts?Huntington disease--another chapter rewritten.Copy number variation, eicosapentaenoic acid and neurological disorders.Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.The relationship between CAG repeat length and clinical progression in Huntington's disease.Reduction in cerebral atrophy associated with ethyl-eicosapentaenoic acid treatment in patients with Huntington's disease.Which diagnostic procedures in the elderly? The case of late-onset Huntington's disease.Simple sequence in brain and nervous system specific proteins.Age, CAG repeat length, and clinical progression in Huntington's disease.Effects of an intensive rehabilitation programme on patients with Huntington's disease: a pilot study.Anti-oligomeric single chain variable domain antibody differentially affects huntingtin and alpha-synuclein aggregates.

P2860

Q24239893-8CE65B4E-B21C-4FED-ADFF-C77D2996C636 Q24239973-B4F940EF-E555-4E2E-80B5-ABCD4FF3C6A5 Q33606063-FE438F86-734C-4DA5-A829-57F01CF4F4D8 Q33752268-A4AF7918-94D7-4947-AA0C-2B5A2BBFB97A Q34014433-A088F445-3EE1-4833-B26E-0F555ADA5072 Q34216757-7C703DBF-1532-4141-A9E1-8AE3A21F2F18 Q34644034-1495F5C4-6DB9-4621-BE23-A0C5F0C7C0B2 Q34692568-D12C63C9-D4D1-4954-9CAE-5F108BE1C818 Q35162891-F9D9CC6E-58DF-4059-A5AB-810039883038 Q35238524-E9AB63A7-61B7-4E35-A117-DB2A1147BF12 Q35449269-EFD15CB2-C8FA-44C5-A4A1-797D29E0021A Q35579484-371C5436-9E93-4A98-9B4F-45FCCD65579E Q35880816-0DECE9D5-42F8-4E3B-B2EB-20005DF5837B Q36045301-F60F0766-F9EE-41C6-882F-3521EF08E5A5 Q36140827-E458D197-E676-46F9-AAA8-C8C7622710DC Q36383240-031C8C92-BE69-455C-8849-11CA1781018A Q36437551-B64FBCCA-582A-4ED9-A0A6-286D7BAF937C Q36528726-50A92D9D-5252-45AD-A760-AD5DD7243BF2 Q37791489-DBBBD360-2515-4C0F-B5DA-C81682160848 Q38170010-F7179AFD-7E86-4EBA-A80E-9286208F7724 Q38202178-22B93FC8-C951-409F-9B74-9816CFBC856E Q38243002-D7F54550-5B56-49D8-8B5F-368EBF9E0A23 Q38689609-632538BA-22C3-44F6-A966-9463A251AEF1 Q38705425-6E0FFC46-5A0B-459F-9A03-69C8F839984E Q38826931-4FA83E5B-7AA0-4B9B-98D3-CBE690CEDFE5 Q39165036-ADB6E9F9-FC8A-4642-9D49-42E2F67E3D76 Q40985899-9FDDC405-8309-4515-AE28-9B8760A4F488 Q41456204-2FB53C61-372A-4195-ACDA-722A67F32C3E Q42587589-9FD0D668-FCF1-40CB-A2CD-20341DFE9EEA Q42743618-0BF6371A-7384-4011-B33E-266FE2095C2F Q43469689-DE7A3B20-6ECB-43C1-883E-5F01EA083652 Q45289699-0EABC780-4A81-4771-AE27-E2691EBF46AD Q45291055-2631F2B3-9885-45A0-970D-13B1EC3EF43C Q45294037-01B3A7B3-C88E-4FF1-B013-7CEF913CD74F Q45296624-190FDAE9-7CC3-43AB-9633-47A930C6A9F6 Q45305597-DBE3C0F5-4CB4-4F52-9D17-B6DF46FE43EA Q45305946-4EED2AA3-8E82-44D0-B3B4-9A4C7B011E38 Q47953864-346FC881-DC9B-42AC-8481-107742B1B637

P2860

Trinucleotide repeat length and progression of illness in Huntington's disease.

http://www.wikidata.org/entity/Q33596210

description

1994 nî lūn-bûn

@nan

1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Trinucleotide repeat length and progression of illness in Huntington's disease.

@ast

Trinucleotide repeat length and progression of illness in Huntington's disease.

@en

type

label

Trinucleotide repeat length and progression of illness in Huntington's disease.

@ast

Trinucleotide repeat length and progression of illness in Huntington's disease.

@en

prefLabel

Trinucleotide repeat length and progression of illness in Huntington's disease.

@ast

Trinucleotide repeat length and progression of illness in Huntington's disease.

@en

P1433

Q33596210-CB7D66DF-FA63-48FB-A2A3-5CEDE90B920B

P1476

Q33596210-7C779C75-573B-4340-B6BC-F60860F36A6C

P2093

Q33596210-04ADFAE6-83A6-47C0-A2D5-865C36BCFABA

Q33596210-2C9E8220-BF27-48FE-B401-8F976BF6FB65

Q33596210-57443E9F-950E-429C-B6EF-3F9F921C0DBD

Q33596210-58ED66E2-E35D-4C7F-8FD6-9613FE5A91CD

Q33596210-617A5840-7791-4FD7-9671-631C15927A59

Q33596210-8345FE8D-7BA6-4249-9CE2-52D4AB6DA9DA

Q33596210-CBB0261A-353D-4698-BD1D-B08EADD8EA5B

Q33596210-E1CA22AE-AD51-47B5-8EDB-63E7FE9F1BA7

Q33596210-F1B52CE8-F36D-436A-A321-0F01E0FB64FF

P2860

Q33596210-4697F681-F149-4D61-8986-DA9BD04B7CD7

Q33596210-58697E93-A998-4DFA-B7EA-3B6AD3B99A85

Q33596210-6C012637-7C08-4957-BF9D-0775812D110F

Q33596210-75E5799C-5D27-4959-9E9D-415C98BDC445

Q33596210-7C355F40-E521-47A9-BCB7-9080CC02EADF

Q33596210-7E73D4FB-7A00-4B25-800F-8143511E222D

Q33596210-A4AF04B3-D316-4303-A20C-C4B6D090036C

Q33596210-AD60E508-040A-45FB-8AC3-5007600E5799

Q33596210-C2697C48-2481-49C3-A297-9088AEB74853

Q33596210-EB9579CD-D261-435E-953A-5DA1E77BD568

P304

Q33596210-811B65ED-C9AA-4F63-AD1C-6EE03CE6919E

P31

Q33596210-8D1B908F-A6EB-4FE6-B86A-66D93A1A5F6D

P356

Q33596210-F76CD661-8634-4E8F-9B30-F2A8C4E3DD29

P407

Q33596210-B9F840F3-5965-4354-A4D3-9913405A045A

P433

Q33596210-42CAE714-D1AF-4DE8-9B1B-0B87F6FA7DBE

P478

Q33596210-3E676F20-56F1-4007-90ED-7B7160238A69

P50

Q33596210-D2A675ED-B29D-4603-925D-A76F490FAFDA

P577

Q33596210-F534B1D5-853F-46E6-B8EE-8312D1BB65C9

P5875

Q33596210-CD8C4D44-6844-48ED-A82D-2354043DF1C1

P698

Q33596210-1B9E8A32-F261-4D4D-9369-70CB85DF24A7

P921

Q33596210-783F5635-0ECA-4BAF-8F6C-3C6F96DB780C

P932

Q33596210-C2CAE8B1-68AD-4696-B3C0-8D4F5DA85AB3

P356

P1433

Journal of Medical Genetics

P1476

Trinucleotide repeat length and progression of illness in Huntington's disease.

@en

P2093

A Feigin

http://www.w3.org/2001/XMLSchema#string

C Shih

http://www.w3.org/2001/XMLSchema#string

C Zimmerman

http://www.w3.org/2001/XMLSchema#string

J Sotack

http://www.w3.org/2001/XMLSchema#string

J Srinidhi

http://www.w3.org/2001/XMLSchema#string

K Bordwell

http://www.w3.org/2001/XMLSchema#string

K Kieburtz

http://www.w3.org/2001/XMLSchema#string

K Steinberg

http://www.w3.org/2001/XMLSchema#string

M MacDonald

http://www.w3.org/2001/XMLSchema#string

P2860

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

Duration of illness in Huntington's disease is not related to age at onset

Mutation size and age at onset in Huntington's disease.

Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease.

Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15.

Trinucleotide repeat length instability and age of onset in Huntington's disease.

A controlled clinical trial of baclofen as protective therapy in early Huntington's disease.

Molecular analysis and clinical correlations of the Huntington's disease mutation.

A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes.

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.

P304

872-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JMG.31.11.872

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

James F. Gusella

P577

1994-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15346600

http://www.w3.org/2001/XMLSchema#string

P698

7853373

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

1016662

http://www.w3.org/2001/XMLSchema#string